Author

S. Horiuchi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cell Biology· 1 Immunology· 1 Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 6 Organism:human· 5 Research Focus:cell type annotation· 4 Research Focus:differential expression· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

K. Oishi· 2 shared R. Moller· 2 shared A. C. Borczuk· 1 shared A. Jiang· 1 shared A. Kobayashi· 1 shared A. Kodra· 1 shared A. Nurani· 1 shared A. P. Kurland· 1 shared

Activity by Year

2020-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

K. Oishi

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Factor XI localization in human deep venous thrombus and function of activated factor XI on venous thrombus formation and hemostasis in rabbit

N. Oguri, T. Gi, E. Nakamura, K. Maekawa, E. Furukoji, H. Okawa, K. Sho, S. Horiuchi, T. Sakae, M. Azuma, Y. Asada, A. Yamashita

This paper investigates the localization of factor XI in human deep vein thrombus and evaluates the effects of FXIa and FXa inhibitors on venous thrombus formation and hemostasis in rabbits.

Research and Practice in Thrombosis and Haemostasis · Feb 1, 2025Peer-reviewedPathology

Human intestinal organoid-derived PDGFRα+ mesenchymal stroma empowers LGR4+ epithelial stem cells

C. JunLong, S. Horiuchi, S. Kuramochi, T. Kawasaki, H. Kawasumi, S. Akiyama, T. Arai, K. Morinaga, T. Kimura, T. Kiyono, H. Akutsu, S. Ishida, A. UMEZAWA

This study shows that organoid-derived mesenchymal stromal cells support the proliferation and functionality of hPSC-derived small intestinal epithelial stem cells in adherent culture.

bioRxiv · Aug 16, 2023 · PreprintCell Biology

Immunological landscape of human lymphoid explants during measles virus infection

J. A. Acklin, A. R. Patel, A. P. Kurland, S. Horiuchi, A. S. Moss, E. J. Degrace, S. Ikegame, J. Carmichael, S. Kowdle, P. Thibault, N. Imai, H. Ueno, B. Tweel, J. R. Johnson, B. R. Rosenberg, , J. K. Lim

The paper infects human lymphoid explants with measles virus and uses scRNA-Seq and flow cytometry to identify B cell preference and T cell resistance, along with ISG protein induction.

bioRxiv · Sep 12, 2022Immunology

SARS-CoV-2 infection results in lasting and systemic perturbations post recovery

J. J. Frere, R. A. Serafini, K. D. Pryce, M. Zazhytska, K. Oishi, I. Golynker, M. Panis, J. Zimering, S. Horiuchi, D. A. Hoagland, R. Moller, A. Ruiz, J. B. Overdevest, A. Kodra, P. D. Canoll, , B. tenOever

This study compares short- and long-term systemic responses to SARS-CoV-2 and IAV in golden hamsters, finding persistent inflammation in olfactory tissues post-recovery.

bioRxiv · Jan 18, 2022Microbiology

Prevalence of floating toe and its relationship with static postural stability in children: The Yamanashi adjunct study of the Japan Environment and Childrens Study (JECS-Y)

T. Fujimaki, M. Wako, K. Koyama, N. Furuya, R. Shinohara, S. Otawa, A. Kobayashi, S. Horiuchi, M. Kushima, Z. Yamagata, H. Haro

This study examines the prevalence of floating toe in children and its association with static postural stability, finding a high prevalence and a correlation between floating toe score and postural stability metrics.

bioRxiv · Jan 13, 2021Physiology

Human organ chip-enabled pipeline to rapidly repurpose therapeutics during viral pandemics

L. Si, H. Bai, M. Rodas, W. Cao, C. Y. Oh, A. Jiang, R. Moller, D. Hoagland, K. Oishi, S. Horiuchi, S. Uhl, D. Blanco-Melo, R. A. Albrecht, W.-C. Liu, T. Jordan, , D. E. Ingber

This paper demonstrates the use of human organ chips to rapidly repurpose therapeutics for viral pandemics, identifying amodiaquine as a potential treatment for SARS-CoV-2.

bioRxiv · Apr 13, 2020 · PreprintMicrobiology